Ponatinix 45 Mg (Ponatinib) – 30 Tablets
$ 685.00
Ponatinix 45 Mg (Ponatinib) from Beacon Pharmaceuticals Ltd. – A beacon of hope on the road to superior cancer treatment Ponatinib – a World-Class Cancer Drug This is a revolutionizing medicine based on oncology – Beacon Pharmaceuticals Ltd’s commitment to provide world-class healthcare solutions against cancer. Ponatinix 45 mg is not only a step towards therapy but also hope for a cancer free world.
Ponatinix 45 mg (Ponatinib) is a prescription medication which is a kinase inhibitor indicated for the treatment:
- Adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.
- Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.
Product Feature:
Manufacturer | : Beacon Pharmaceuticals PLC. |
Indication | : Antineoplastic (Cancer) Medicine. |
Generic | : Ponatinib |
Formulation | : Tablet |
Pack Size | : 30 Tablets |
Strengths | : 45 Mg |
Storage | : Below 30°C |
You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Ponatinix 45 Mg (Ponatinib) medicine.
Reviews
There are no reviews yet.